12-1832290-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_172364.5(CACNA2D4):c.2551+8449A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.738 in 152,082 control chromosomes in the GnomAD database, including 42,190 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 42190 hom., cov: 32)
Consequence
CACNA2D4
NM_172364.5 intron
NM_172364.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.60
Publications
3 publications found
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
LRTM2 (HGNC:32443): (leucine rich repeats and transmembrane domains 2) Predicted to enable Roundabout binding activity and heparin binding activity. Predicted to be involved in axon guidance and negative chemotaxis. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.966 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA2D4 | ENST00000382722.10 | c.2551+8449A>G | intron_variant | Intron 26 of 37 | 1 | NM_172364.5 | ENSP00000372169.4 | |||
| LRTM2 | ENST00000299194.6 | c.658+765T>C | intron_variant | Intron 4 of 4 | 2 | NM_001039029.3 | ENSP00000299194.1 | |||
| CACNA2D4 | ENST00000586184.5 | c.2551+8449A>G | intron_variant | Intron 26 of 36 | 5 | ENSP00000465060.1 | ||||
| CACNA2D4 | ENST00000587995.5 | c.2476+8449A>G | intron_variant | Intron 25 of 36 | 5 | ENSP00000465372.1 | ||||
| CACNA2D4 | ENST00000585708.5 | c.2359+8449A>G | intron_variant | Intron 26 of 36 | 5 | ENSP00000467697.1 | ||||
| CACNA2D4 | ENST00000588077.5 | c.2359+8449A>G | intron_variant | Intron 26 of 37 | 5 | ENSP00000468530.1 | ||||
| CACNA2D4 | ENST00000444595.6 | n.*797+8449A>G | intron_variant | Intron 26 of 36 | 1 | ENSP00000403371.2 | ||||
| CACNA2D4 | ENST00000537784.5 | n.391+8449A>G | intron_variant | Intron 4 of 14 | 1 | ENSP00000440231.2 |
Frequencies
GnomAD3 genomes AF: 0.739 AC: 112234AN: 151964Hom.: 42170 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
112234
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.738 AC: 112295AN: 152082Hom.: 42190 Cov.: 32 AF XY: 0.749 AC XY: 55644AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
112295
AN:
152082
Hom.:
Cov.:
32
AF XY:
AC XY:
55644
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
25419
AN:
41460
American (AMR)
AF:
AC:
12274
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2535
AN:
3472
East Asian (EAS)
AF:
AC:
5113
AN:
5172
South Asian (SAS)
AF:
AC:
4145
AN:
4820
European-Finnish (FIN)
AF:
AC:
8869
AN:
10580
Middle Eastern (MID)
AF:
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
AC:
51379
AN:
67986
Other (OTH)
AF:
AC:
1585
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1447
2894
4340
5787
7234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3127
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.